(3-HYDROXYAZETIDIN-1-YL)-((1R,2R)-2-(2-METHYL-5-(4-(TRIFLUOROMETHYL)PHENOXY)INDAZOL-7-YL)CYCLOPROPYL)METHANONE
UNII CY9SN37GAY
Substance Identification & Data
This profile provides standardized clinical and technical data for (3-hydroxyazetidin-1-yl)-((1r,2r)-2-(2-methyl-5-(4-(trifluoromethyl)phenoxy)indazol-7-yl)cyclopropyl)methanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CY9SN37GAY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3034813-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H20F3N3O3 KHGVGNIPYOSXFC-PKOBYXMFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3-hydroxyazetidin-1-yl)-((1r,2r)-2-(2-methyl-5-(4-(trifluoromethyl)phenoxy)indazol-7-yl)cyclopropyl)methanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.